Guidance

Newborn blood spot screening: laboratory guide for IMDs

This publication covers all 6 inherited metabolic diseases (IMDs) and incorporates the previous PKU and MCADD laboratory handbooks.

From:
Public Health England
Published
14 July 2015
Last updated
8 September 2017 — See all updates

Documents

A laboratory guide to newborn blood spot screening for inherited metabolic diseases

Ref: PHE publications gateway number 2017291

PDF, 1010 KB, 140 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The document covers screening and diagnostic protocols and initial clinical referral guidelines for the 6 inherited metabolic diseases:

  • phenylketonuria (PKU)
  • medium-chain acyl-CoA dehydrogenase deficiency (MCADD)
  • maple syrup urine disease (MSUD)
  • isovaleric acidaemia (IVA)
  • glutaric aciduria type 1 (GA1)
  • homocystinuria (pyridoxine unresponsive) (HCU)
Published 14 July 2015
Last updated 8 September 2017 + show all updates

  1. Updated version of guidance document.

  2. First published.

Related content